Latest filing published 27 Sept 2017 for Pure Bioscience, INC., €4,588.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -31.4%Entry US$1.02 · Close at T+365 US$0.70
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William Otis: trading record in brief
All filings by William Otis on record concern Pure Bioscience, Inc. The record holds 5 filings, for trades running from 23 October 2013 to 25 September 2017.
The open-market record is one-sided, with 2 purchases worth €25k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 2 share grants and 1 option exercise.
On 27 September 2017 came the latest disclosure, an option exercise for €4,588 in Pure Bioscience, Inc. The last insider purchase was made public on 9 September 2015, 4,079 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to William Otis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,066 shares@ US$0.60100.0% of flowCommon StockSEC:0001209191-17-054170:0
- 150,000 shares0Common StockSEC:0001209191-17-041854:0
- 22,666 shares@ US$0.75Common StockSEC:0001209191-15-069952:0Canonical exit: 30 Oct 2014 (T+90)
- 20,000 shares@ US$0.85Common StockSEC:0001209191-14-050718:0Canonical exit: 30 Oct 2014 (T+90)
- 200,000 shares0Common StockSEC:0001209191-13-049426:0
5 of 5 declarations
